May 3, 2018 / 11:14 AM / 6 months ago

BRIEF-Immunovaccine Has Applied To List Its Common Shares On Nasdaq

May 3 (Reuters) - Immunovaccine Inc:

* IMMUNOVACCINE INC. HAS APPLIED TO LIST ITS COMMON SHARES ON NASDAQ, ANNOUNCES REVERSE STOCK SPLIT

* IMMUNOVACCINE INC - IMPLEMENTING A CONSOLIDATION OF ITS OUTSTANDING COMMON SHARES, AND CHANGING CORPORATION NAME TO IMV INC

* IMMUNOVACCINE - SHARE CONSOLIDATION WILL BE DONE ON BASIS OF 1 NEW SHARE FOR EVERY 3.2 CURRENTLY OUTSTANDING SHARES

* IMMUNOVACCINE - CURRENTLY ANTICIPATES COMMON SHARES WOULD BEGIN TRADING ON NASDAQ BEFORE END OF Q2 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below